Stock Information
symbol line chart

CHDChurch & Dwight Co., Inc.

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Matthew T. Farrell

Location

New Jersey, USA

Exchange

NYSE

Website

https://churchdwight.com

Summary

Church & Dwight Co.

Company Info

CEO

Matthew T. Farrell

Location

New Jersey, USA

Exchange

NYSE

Website

https://churchdwight.com

Summary

Church & Dwight Co.

AI Insights for CHD
5 min read

Quick Summary

Church & Dwight Co., Inc. is a U.S.-based consumer products company headquartered in Ewing, New Jersey. The company develops, manufactures, and markets household, personal care, and specialty products across its Consumer Domestic, Consumer International, and Specialty Products Division segments. Its portfolio includes well-known everyday brands such as Arm & Hammer, OxiClean, Waterpik, TheraBreath, and other household and personal care labels. The company sells products primarily to mass retailers, grocery stores, drugstores, club stores, e-commerce platforms, and international distributors. Its main customers are consumers seeking value-oriented household cleaning, laundry, oral care, deodorizing, pet care, and personal wellness products, as well as retailers that rely on high-repeat-purchase consumer staples categories.

Strengths

•

Church & Dwight’s primary strength is its portfolio of durable everyday brands, including Arm & Hammer, OxiClean, Waterpik, and TheraBreath.

•

These brands operate in categories with frequent repeat purchasing, which helps create stable revenue and cash flow.

•

The company also has defensive characteristics, reflected in its low beta and exposure to essential household and personal care products.

•

Its e-commerce penetration is rising, with online sales representing more than one-fifth of consumer sales in the latest reported period.

•

Church & Dwight also has a dividend-growth profile, a dividend yield of about 1.16%, and a history of dividend increases that appeal to long-term income-oriented investors.

Key Risks

•

Church & Dwight faces risks from inflation, commodity costs, freight expenses, currency movements, tariffs, and changing consumer behavior.

•

If household budgets become pressured by higher energy prices or broader inflation, consumers may trade down to private-label alternatives or reduce discretionary personal care purchases.

•

The company also faces regulatory and litigation risks because it sells consumer health, personal care, and household products.

•

Acquisitions and divestitures create execution risk, especially if acquired brands require impairments or fail to meet growth expectations.

What to Watch

During the most recent quarter, Church & Dwight reported stronger-than-expected results, with revenue growth and adjusted EPS ahead of analyst estimates.
Domestic and international consumer sales increased, while Specialty Products declines created some offset.
Organic sales growth remained solid, and gross margin improved, suggesting that pricing, productivity, mix, or cost controls helped profitability.
Online sales reached 20.7% of consumer sales, showing that e-commerce remains an increasingly important distribution channel.
The quarter also included attention on portfolio management, including the planned sale of the VitaFusion and L’il Critters vitamin brands to Piping Rock Health Products and the related expected after-tax charge.

Price Drivers

•

Church & Dwight’s stock price is being driven by a mix of earnings performance, margin trends, organic sales growth, brand strength, and valuation.

•

Recent Q3 results were a positive driver because adjusted EPS of $0.79 beat estimates of $0.68 and revenue of about $1.51 billion exceeded expectations.

•

Organic sales growth above 4%, improving gross margin, and stronger domestic and international sales supported investor confidence.

•

The stock also benefits from defensive consumer staples characteristics, including a low beta of 0.482 and demand for everyday household products.

•

Offsetting factors include a relatively high price-to-earnings ratio near 33.4, EV/EBITDA around 20.9, weak Specialty Products performance, and softer Q4 EPS guidance versus consensus.

Recent News

•

Recent news for Church & Dwight has been generally mixed but tilted positive because of strong quarterly earnings and organic sales growth.

•

Shares rose after Q3 adjusted EPS of $0.79 beat estimates and revenue grew 3.8% to about $1.51 billion.

•

The company reaffirmed full-year sales growth guidance and expects adjusted EPS to rise, although Q4 EPS guidance was below consensus.

•

Church & Dwight also announced that it will sell its VitaFusion and L’il Critters vitamin brands, along with related trademarks, licenses, and Washington facilities, to Piping Rock Health Products.

•

Another recent development was TheraBreath’s launch of a dentist-formulated toothpaste line, which expands the brand’s oral care presence across Amazon, Target, Walmart, and direct online channels.

Market Trends

•

Church & Dwight is affected by broader consumer staples trends, including resilient demand for everyday products, private-label competition, and inflation-driven pressure on household spending.

•

E-commerce is becoming increasingly important in consumer products, and Church & Dwight’s online sales share shows that digital channels are now a major part of its growth story.

•

The clean beauty and wellness markets are expanding, with consumers showing more interest in sustainable, plant-based, multifunctional, and health-oriented products.

•

At the same time, commodity, freight, marketing, and tariff-related costs can pressure margins across the sector.

•

Large consumer products companies are also using innovation, pricing, acquisitions, divestitures, and cost controls to defend market share and maintain earnings growth.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on CHD

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show